Participant to WHO Consultation on Ebola

  • Michael Selgelid (Contributor)

Activity: External Academic EngagementCommittees and working groups


Participant, WHO Consultation: “Beyond Phase 1 Trials, What Could be the Clinical and Regulatory Pathway for Ebola Vaccines? Objectives and Key Design Elements for Phase 2 and 3 Trials of Ebola Vaccines.” Gave presentation on “Ethics Perspective on Proposed Emergency Use of Vaccine in Affected Countries in Parallel with Phase 2 Clinical Trials.” Geneva.
Work forWHO - World Health Organization Switzerland, Switzerland